It's all about the CD3+ T-cells: how circulating immune cell subset analyses can predict early relapse in Hodgkin lymphoma.

Autor: Moreira J; Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago , IL , USA.; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University , Chicago , IL , USA., Platanias LC; Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago , IL , USA.; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.; Department of Medicine, Jesse Brown VA Medical Center , Chicago , IL , USA., Adekola KUA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago , IL , USA.; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University , Chicago , IL , USA.
Jazyk: angličtina
Zdroj: Leukemia & lymphoma [Leuk Lymphoma] 2019 Oct; Vol. 60 (10), pp. 2345-2347. Date of Electronic Publication: 2019 Aug 27.
DOI: 10.1080/10428194.2019.1646909
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje